| Signatures of mutational processes in human cancer LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ... nature 500 (7463), 415-421, 2013 | 11235 | 2013 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 3028* | 2020 |
| Landscape of somatic mutations in 560 breast cancer whole-genome sequences S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ... Nature 534 (7605), 47-54, 2016 | 2591 | 2016 |
| Mutational processes molding the genomes of 21 breast cancers S Nik-Zainal, LB Alexandrov, DC Wedge, P Van Loo, CD Greenman, ... Cell 149 (5), 979-993, 2012 | 2322 | 2012 |
| The landscape of cancer genes and mutational processes in breast cancer PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ... Nature 486 (7403), 400-404, 2012 | 2049 | 2012 |
| A pooled analysis of bone marrow micrometastasis in breast cancer S Braun, FD Vogl, B Naume, W Janni, MP Osborne, RC Coombes, ... New England journal of medicine 353 (8), 793-802, 2005 | 1752 | 2005 |
| The life history of 21 breast cancers S Nik-Zainal, P Van Loo, DC Wedge, LB Alexandrov, CD Greenman, ... Cell 149 (5), 994-1007, 2012 | 1747 | 2012 |
| Fibroblast heterogeneity and immunosuppressive environment in human breast cancer A Costa, Y Kieffer, A Scholer-Dahirel, F Pelon, B Bourachot, M Cardon, ... Cancer cell 33 (3), 463-479. e10, 2018 | 1743 | 2018 |
| Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept … C Le Tourneau, JP Delord, A Gonçalves, C Gavoille, C Dubot, N Isambert, ... The lancet oncology 16 (13), 1324-1334, 2015 | 1215 | 2015 |
| HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures H Davies, D Glodzik, S Morganella, LR Yates, J Staaf, X Zou, ... Nature medicine 23 (4), 517-525, 2017 | 1182 | 2017 |
| Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer Y Kieffer, HR Hocine, G Gentric, F Pelon, C Bernard, B Bourachot, ... Cancer discovery 10 (9), 1330-1351, 2020 | 811 | 2020 |
| Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation T Popova, E Manié, G Rieunier, V Caux-Moncoutier, C Tirapo, T Dubois, ... Cancer research 72 (21), 5454-5462, 2012 | 736 | 2012 |
| Phyllodes tumours of the breast: a consensus review BY Tan, G Acs, SK Apple, S Badve, IJ Bleiweiss, E Brogi, JP Calvo, ... Histopathology 68 (1), 5-21, 2016 | 554 | 2016 |
| Infiltrating lobular carcinoma of the breast: clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns X Sastre‐Garau, M Jouve, B Asselain, A Vincent‐Salomon, P Beuzeboc, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1996 | 546 | 1996 |
| A new model of patient tumor-derived breast cancer xenografts for preclinical assays E Marangoni, A Vincent-Salomon, N Auger, A Degeorges, F Assayag, ... Clinical cancer research 13 (13), 3989-3998, 2007 | 521 | 2007 |
| Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes JMC Tubio, Y Li, YS Ju, I Martincorena, SL Cooke, M Tojo, G Gundem, ... Science 345 (6196), 1251343, 2014 | 516 | 2014 |
| Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer RN Ramos, Y Missolo-Koussou, Y Gerber-Ferder, CP Bromley, M Bugatti, ... Cell 185 (7), 1189-1207. e25, 2022 | 507 | 2022 |
| Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized … JY Pierga, FC Bidard, C Mathiot, E Brain, S Delaloge, S Giachetti, ... Clinical Cancer Research 14 (21), 7004-7010, 2008 | 462 | 2008 |
| Oxidative stress promotes myofibroblast differentiation and tumour spreading A Toullec, D Gerald, G Despouy, B Bourachot, M Cardon, S Lefort, ... EMBO molecular medicine 2 (6), 211-230, 2010 | 406 | 2010 |
| Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms F Pelon, B Bourachot, Y Kieffer, I Magagna, F Mermet-Meillon, I Bonnet, ... Nature communications 11 (1), 404, 2020 | 396 | 2020 |
fabien reyalInstitut Curie. Department of SurgeryVerified email at curie.fr
